N6-methyladenosine modification regulates ferroptosis through autophagy signaling pathway in hepatic stellate cells
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Ferroptosis is a recently identified non-apoptotic form of cell death characterized by iron-dependent lipid peroxidation. However, the underlying exact mechanisms remain poorly understood. Here, we report that the total levels of N6-methyladenosine (m6A) modification are evidently increased upon exposure to ferroptosis-inducing compounds due to the upregulation of methylase METTL4 and the downregulation of demethylase FTO. Interestingly, RNA-seq shows that m6A modification appears to trigger autophagy activation by stabilizing BECN1 mRNA, which may be the potential mechanism for m6A modification-enhanced HSC ferroptosis. Importantly, YTHDF1 is identified as a key m6A reader protein for BECN1 mRNA stability, and knockdown of YTHDF1 could prevent BECN1 plasmid-induced HSC ferroptosis. Noteworthy, YTHDF1 promotes BECN1 mRNA stability and autophagy activation via recognizing the m6A binding site within BECN1 coding regions. In mice, erastin treatment alleviates liver fibrosis by inducing HSC ferroptosis. HSC-specific inhibition of m6A modification could impair erastin-induced HSC ferroptosis in murine liver fibrosis. Moreover, we retrospectively analyzed the effect of sorafenib on HSC ferroptosis and m6A modification in advanced fibrotic patients with hepatocellular carcinoma (HCC) receiving sorafenib monotherapy. Attractively, the m6A modification upregulation, autophagy activation, and ferroptosis induction occur in human HSCs. Overall, these findings reveal novel signaling pathways and molecular mechanisms of ferroptosis, and also identify m6A modification-dependent ferroptosis as a potential target for the treatment of liver fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Lin, X., Chai, G., Wu, Y., Li, J., Chen, F., Liu, J., Luo, G., Tauler, J., Du, J., Lin, S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09865-9 · Cited by 510 · cited 2×
“The stability of BECN1 was detected through western blot analysis as described previously [28].”
MethodRetractedZhang, Z., Zhao, S., Yao, Z., Wang, L., Shao, J., Chen, A., Zhang, F., & Zheng, S. (2017) · Redox Biology · doi:10.1016/j.redox.2016.12.021 · Cited by 108 · cited 1×
“We previously reported that the pathological and pathophysiological condition of liver fibrosis could alleviated by triggering the activation of apoptosis [4], senescence [5], necroptosis [6], lipocyte phenotype [7], and prevention of the proliferation [8], contractile [9], glycolytic [10] and pericyte [11] in HSCs.”
BackgroundSelf-citationRetractedRegulation of Ferroptotic Cancer Cell Death by GPX4
Yang, W. S., SriRamaratnam, R., Welsch, M. E., Shimada, K., Skouta, R., Viswanathan, V. S., Cheah, J. H., Clemons, P. A., Shamji, A. F., Clish, C. B., et al. (2014) · Cell · doi:10.1016/j.cell.2013.12.010 · Cited by 7,713 · cited 2×
“Consistent with our previous findings [16,29], treatment with erastin, sorafenib, and RSL3 evidently inhibited cell viability in both rat (HSC-T6), human (HSC-LX2) HSC cells and primary HSCs, but ferroptosis inhibitor (ferrostatin-1) rather than necroptosis inhibitor (necrostatin-1) and apoptosis inhibitor (ZVAD-FMK)…”
BackgroundResultN6-methyladenosine-dependent regulation of messenger RNA stability
Wang, X., Lu, Z., Gomez, A., Hon, G. C., Yue, Y., Han, D., Fu, Y., Parisien, M., Dai, Q., Jia, G., et al. (2014) · Nature · doi:10.1038/nature12730 · Cited by 4,558 · cited 1×
“It has been reported that m6A modification functions in condition of its recognition by m6A reader proteins [31].”
BackgroundN6-methyladenosine Modulates Messenger RNA Translation Efficiency
Wang, X., Zhao, B. S., Roundtree, I. A., Lu, Z., Han, D., Ma, H., Weng, X., Chen, K., Shi, H., & He, C. (2015) · Cell · doi:10.1016/j.cell.2015.05.014 · Cited by 3,483 · cited 2×
“Accumulating evidence has demonstrated that YTHDF1 can recognize m6A methylated mRNA and promote the post-transcriptional regulation of its targets [32].”
BackgroundGuidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1
Klionsky, D. J., Abdel-Aziz, A. K., Abdelfatah, S., Abdellatif, M., Abdoli, A., Abel, S., Abeliovich, H., Abildgaard, M. H., Abudu, Y. P., Acevedo-Arozena, A., et al. (2021) · Autophagy · doi:10.1080/15548627.2020.1797280 · Cited by 2,897
Self-citationPost-transcriptional gene regulation by mRNA modifications
Zhao, B. S., Roundtree, I. A., & He, C. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.132 · Cited by 2,420 · cited 4×
“Overall, these results fully confirmed that erastin, sorafenib, and RSL3 can trigger HSC ferroptosis in vitro. m6A modification can regulate a variety of cell fates including apoptosis, necroptosis, senescence, and endothelium-mesenchymal transition (EMT).”
BackgroundInfluentialThe role of iron and reactive oxygen species in cell death
Dixon, S. J., & Stockwell, B. R. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1416 · Cited by 2,381 · cited 1×
“Distinct from classic morphological features of apoptosis, necrosis, necroptosis, pyroptosis, and senescence, ferroptosis is a recently identified form of programmed cell death [15].”
BackgroundThe role of m6A modification in the biological functions and diseases
Jiang, X., Liu, B., Nie, Z., Duan, L., Xiong, Q., Jin, Z., Yang, C., & Chen, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00450-x · Cited by 2,335 · cited 1×
“m6A-binding proteins with YTH domain, including YTHDF1/2/3, YTHDC1/2, have been recognized to be the “readers” of m6A motif, which can regulate gene expression through recognize and bind to the m6A modified transcript [46].”
BackgroundAutophagy promotes ferroptosis by degradation of ferritin
Hou, W., Xie, Y., Song, X., Sun, X., Lotze, M. T., Zeh, H. J., Kang, R., & Tang, D. (2016) · Autophagy · doi:10.1080/15548627.2016.1187366 · Cited by 2,332
Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy
Mancias, J. D., Wang, X., Gygi, S. P., Harper, J. W., & Kimmelman, A. C. (2014) · Nature · doi:10.1038/nature13148 · Cited by 2,084 · cited 1×
“Notably, NCOA4-dependent FTH1 degradation plays a central role in facilitating ferritinophagy [30].”
BackgroundSun, X., Ou, Z., Chen, R., Niu, X., Chen, D., Kang, R., & Tang, D. (2016) · Hepatology · doi:10.1002/hep.28251 · Cited by 2,012 · cited 2×
“Lipid peroxidation, iron overload, lipid ROS accumulation, and glutathione (GSH) depletion are hallmarks of ferroptotic cells [29].”
BackgroundResultFerroptosis is an autophagic cell death process
Gao, M., Monian, P., Pan, Q., Zhang, W., Xiang, J., & Jiang, X. (2016) · Cell Research · doi:10.1038/cr.2016.95 · Cited by 1,899 · cited 1×
“Recent studies indicated that cellular autophagy plays an important role in ferroptosis [41,42].”
BackgroundRNA N6-methyladenosine modification in cancers: current status and perspectives
Deng, X., Su, R., Weng, H., Huang, H., Li, Z., & Chen, J. (2018) · Cell Research · doi:10.1038/s41422-018-0034-6 · Cited by 845 · cited 1×
“Additionally, m6A binding proteins including heterogeneous nuclear ribonucleoprotein A2/B1 (HNRNPA2B1), insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs), YTH-domain- containing protein 1/2 (YTHDC1/ 2), and YTH domain family 1/2/3 (YTHDF1/2/3) bind to the m6A motif to affect RNA stability or function [19].”
BackgroundHistone H3 trimethylation at lysine 36 guides m6A RNA modification co-transcriptionally
Huang, H., Weng, H., Zhou, K., Wu, T., Zhao, B. S., Sun, M., Chen, Z., Deng, X., Xiao, G., Auer, F., et al. (2019) · Nature · doi:10.1038/s41586-019-1016-7 · Cited by 677 · cited 3×
“The sensitivity of liver cells to ferroptosis inducers was different, and specifically targeting HSC ferroptosis will be the research direction in the future. m6A has been identified as the predominant internal modification of mRNAs in eukaryotic uncovering the consensus motif RRACH [37].”
BackgroundInfluentialRNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3
Niu, Y., Lin, Z., Wan, A., Chen, H., Liang, H., Sun, L., Wang, Y., Li, X., Xiong, X.-F., Wei, B., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1004-4 · Cited by 593 · cited 1×
“reported that m6A demethylases FTO is up-regulated in human breast cancer, and silencing FTO can significantly inhibit breast cancer cell proliferation and promote cell apoptosis [40].”
BackgroundSelf-citationChaperone-mediated autophagy is involved in the execution of ferroptosis
Wu, Z., Geng, Y., Lu, X., Shi, Y., Wu, G., Zhang, M., Shan, B., Pan, H., & Yuan, J. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1819728116 · Cited by 577 · cited 1×
“Recent studies indicated that cellular autophagy plays an important role in ferroptosis [41,42].”
Backgroundm6A facilitates hippocampus-dependent learning and memory through YTHDF1
Shi, H., Zhang, X., Weng, Y.-L., Lu, Z., Liu, Y., Lu, Z., Li, J., Hao, P., Zhang, Y., Zhang, F., et al. (2018) · Nature · doi:10.1038/s41586-018-0666-1 · Cited by 546 · cited 1×
“In mouse brain, YTHDF1 facilitates translation of m6A-methylated neuronal mRNAs in response to neuronal stimulation, and this process contributes to learning and memory [49].”
BackgroundSelf-citationClockophagy is a novel selective autophagy process favoring ferroptosis
Yang, M., Chen, P., Liu, J., Zhu, S., Kroemer, G., Klionsky, D. J., Lotze, M. T., Zeh, H. J., Kang, R., & Tang, D. (2019) · Science Advances · doi:10.1126/sciadv.aaw2238 · Cited by 489 · cited 1×
“In particular, the activation of selective autophagy such as NCOA4-mediated ferritinophagy, RAB7A-facilitated lipophagy [43], ARNTL-induced clockophagy [44], and PINK1-activated mitophagy [45], has been reported to promote ferroptosis.”
BackgroundNedd4 ubiquitylates VDAC2/3 to suppress erastin-induced ferroptosis in melanoma
Yang, Y., Luo, M., Zhang, K., Zhang, J., Gao, T., Connell, D. O., Yao, F., Mu, C., Cai, B., Shang, Y., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14324-x · Cited by 480 · cited 1×
“According to the manufacturer’s instruction [26], Iron Assay Kit (ab83366, Abcam) was used to measure cellular iron concentration.”
MethodZhang, Z., Yao, Z., Wang, L., Ding, H., Shao, J., Chen, A., Zhang, F., & Zheng, S. (2018) · Autophagy · doi:10.1080/15548627.2018.1503146 · Cited by 474 · cited 5×
“We found that RNA binding proteins ELAVL1 and ZFP36 could trigger HSC ferroptosis to alleviate liver fibrosis by regulating autophagy pathway [12,13].”
BackgroundMethodResultInfluentialSelf-citationZhang, Z., Guo, M., Li, Y., Shen, M., Kong, D., Shao, J., Ding, H., Tan, S., Chen, A., Zhang, F., et al. (2020) · Autophagy · doi:10.1080/15548627.2019.1687985 · Cited by 462 · cited 10×
“We found that RNA binding proteins ELAVL1 and ZFP36 could trigger HSC ferroptosis to alleviate liver fibrosis by regulating autophagy pathway [12,13].”
BackgroundMethodInfluentialSelf-citationLi, Q., Ni, Y., Zhang, L., Jiang, R., Xu, J., Yang, H., Hu, Y., Qiu, J., Pu, L., Tang, J., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00453-8 · Cited by 380
m6A mRNA methylation controls autophagy and adipogenesis by targeting Atg5 and Atg7
Wang, X., Wu, R., Liu, Y., Zhao, Y., Bi, Z., Yao, Y., Liu, Q., Shi, H., Wang, F., & Wang, Y. (2020) · Autophagy · doi:10.1080/15548627.2019.1659617 · Cited by 380 · cited 1×
“demonstrated that m6A modification promotes adipogenesis through activating autophagy [39].”
BackgroundSelf-citationYTHDF1 links hypoxia adaptation and non-small cell lung cancer progression
Shi, Y., Fan, S., Wu, M., Zuo, Z., Li, X., Jiang, L., Shen, Q., Xu, P., Zeng, L., Zhou, Y., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12801-6 · Cited by 363 · cited 1×
“In non-small cell lung cancer (NSCLC), YTHDF1 deficiency inhibits the proliferation of NSCLC cell and the formation of xenograft tumor by regulating the translational efficiency of CDK2, CDK4, and cyclin D1 [48].”
BackgroundThe small GTPase Rab7 as a central regulator of hepatocellular lipophagy
Schroeder, B., Schulze, R. J., Weller, S. G., Sletten, A. C., Casey, C. A., & McNiven, M. A. (2015) · Hepatology · doi:10.1002/hep.27667 · Cited by 329 · cited 1×
“In particular, the activation of selective autophagy such as NCOA4-mediated ferritinophagy, RAB7A-facilitated lipophagy [43], ARNTL-induced clockophagy [44], and PINK1-activated mitophagy [45], has been reported to promote ferroptosis.”
BackgroundLi, C., Zhang, Y., Cheng, X., Yuan, H., Zhu, S., Liu, J., Wen, Q., Xie, Y., Liu, J., Kroemer, G., et al. (2018) · Developmental Cell · doi:10.1016/j.devcel.2018.07.012 · Cited by 258
New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis
Wang, Y., Gao, J., Zhang, D., Zhang, J., Ma, J., & Jiang, H. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.02.027 · Cited by 231 · cited 1×
“showed that sorafenib can inhibit intrahepatic fibrosis, hydroxyproline accumulation and collagen deposition [36].”
BackgroundSelf-citationBECN1 is a new driver of ferroptosis
Kang, R., Zhu, S., Zeh, H. J., Klionsky, D. J., & Tang, D. (2018) · Autophagy · doi:10.1080/15548627.2018.1513758 · Cited by 189 · cited 1×
“2 sorafenib, erastin), GPX4 inhibition (such as FIN56, altretamine, RSL3, FINO2), and physiological conditions (such as cystine deprivation, amino acid starvation, high extracellular glutamate) are reported to induce ferroptosis [17].”
BackgroundThe BRD7-P53-SLC25A28 axis regulates ferroptosis in hepatic stellate cells
Zhang, Z., Guo, M., Shen, M., Kong, D., Zhang, F., Shao, J., Tan, S., Wang, S., Chen, A., Cao, P., et al. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101619 · Cited by 189 · cited 1×
“Moreover, we also revealed that mitochondrial iron metabolism pathway may regulate HSC ferroptosis via BRD7/P53/SLC25A28 axis [14].”
BackgroundSelf-citationJia, Y., Wang, F., Guo, Q., Li, M., Wang, L., Zhang, Z., Jiang, S., Jin, H., Chen, A., Tan, S., et al. (2018) · Redox Biology · doi:10.1016/j.redox.2018.09.007 · Cited by 163 · cited 1×
“We previously reported that the pathological and pathophysiological condition of liver fibrosis could alleviated by triggering the activation of apoptosis [4], senescence [5], necroptosis [6], lipocyte phenotype [7], and prevention of the proliferation [8], contractile [9], glycolytic [10] and pericyte [11] in HSCs.”
BackgroundSelf-citationLiu, X., Liu, J., Xiao, W., Zeng, Q., Bo, H., Zhu, Y., Gong, L., He, D., Xing, X., Li, R., et al. (2020) · Hepatology · doi:10.1002/hep.31222 · Cited by 162 · cited 1×
“Mutations of BECN1 were constructed by PCR-based methods according to previous reports [24].”
MethodHepatic stellate cell activation and pro-fibrogenic signals
Gandhi, C. R. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.06.001 · Cited by 161 · cited 1×
“The deposition of extracellular matrix is a central event in liver fibrosis, and the myofibroblasts matrix is mainly produced by activated HSCs [2].”
BackgroundSong, T., Yang, Y., Wei, H., Xie, X., Lü, J., Zeng, Q., Peng, J., Zhou, Y., Jiang, S., & Peng, J. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz312 · Cited by 153
Kuo, C., Chiu, V. J.-Y., Hsieh, P., Chun-Yen, H., Huang, S.-T. J., Tzeng, I., Tsai, F., Chen, M., Liu, C.-T., & Chen, Y.-R. (2020) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2020.07.014 · Cited by 106
Zhang, Z., Yao, Z., Zhao, S., Shao, J., Chen, A., Zhang, F., & Zheng, S. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.255 · Cited by 97 · cited 1×
“We previously reported that the pathological and pathophysiological condition of liver fibrosis could alleviated by triggering the activation of apoptosis [4], senescence [5], necroptosis [6], lipocyte phenotype [7], and prevention of the proliferation [8], contractile [9], glycolytic [10] and pericyte [11] in HSCs.”
BackgroundSelf-citationLi, Y., Jin, C., Shen, M., Wang, Z., Tan, S., Chen, A., Wang, S., Shao, J., Zhang, F., Zhang, Z., et al. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.09.008 · Cited by 92 · cited 1×
“recently reported that artemether-induced ferroptosis alleviates liver fibrosis via IRP2/Iron/ROS axis [34].”
BackgroundSelf-citationMuratori, L., Muratori, P., Lanzoni, G., Ferri, S., & Lenzi, M. (2010) · Hepatology · doi:10.1002/hep.23924 · Cited by 67
Zhang, F., Lü, S., He, J., Jin, H., Wang, F., Wu, L., Shao, J., Chen, A., & Zheng, S. (2017) · Theranostics · doi:10.7150/thno.22237 · Cited by 67 · cited 1×
“We previously reported that the pathological and pathophysiological condition of liver fibrosis could alleviated by triggering the activation of apoptosis [4], senescence [5], necroptosis [6], lipocyte phenotype [7], and prevention of the proliferation [8], contractile [9], glycolytic [10] and pericyte [11] in HSCs.”
BackgroundSelf-citationXing, P., Niu, Y., Mu, R., Wang, Z., Xie, D., Li, H., Dong, L., & Wang, C. (2020) · Nature Communications · doi:10.1038/s41467-020-15323-8 · Cited by 64 · cited 1×
“1 ml/20 g body weight), according to our previous reports [23].”
ResultHepatic fibrosis: A convergent response to liver injury that is reversible
Wang, S., & Friedman, S. L. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.03.011 · Cited by 62 · cited 1×
“Consequently, elimination of HSCs is a main therapeutic strategy in the development of anti-fibrotic therapy [3].”
BackgroundWang, F., Jia, Y., Li, M., Wang, L., Shao, J., Guo, Q., Tan, S., Ding, H., Chen, A., Zhang, F., et al. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0324-8 · Cited by 55 · cited 1×
“We previously reported that the pathological and pathophysiological condition of liver fibrosis could alleviated by triggering the activation of apoptosis [4], senescence [5], necroptosis [6], lipocyte phenotype [7], and prevention of the proliferation [8], contractile [9], glycolytic [10] and pericyte [11] in HSCs.”
BackgroundSelf-citationMcDaniel, K., Meng, F., Wu, N., Sato, K., Venter, J., Bernuzzi, F., Invernizzi, P., Zhou, T., Kyritsi, K., Wan, Y., et al. (2017) · Hepatology · doi:10.1002/hep.28831 · Cited by 52 · cited 1×
“Laser capture microdissection was used to isolate primary HSCs from human liver tissue according to our reports previously [22].”
MethodXu, W., Lu, C., Zhang, F., Shao, J., Yao, S., & Zheng, S. (2017) · The FEBS Journal · doi:10.1111/febs.13956 · Cited by 36 · cited 1×
“We previously reported that the pathological and pathophysiological condition of liver fibrosis could alleviated by triggering the activation of apoptosis [4], senescence [5], necroptosis [6], lipocyte phenotype [7], and prevention of the proliferation [8], contractile [9], glycolytic [10] and pericyte [11] in HSCs.”
BackgroundSelf-citationBian, M., He, J., Jin, H., Lian, N., Shao, J., Guo, Q., Wang, S., Zhang, F., & Zheng, S. (2019) · APOPTOSIS · doi:10.1007/s10495-019-01568-2 · Cited by 30 · cited 1×
“We previously reported that the pathological and pathophysiological condition of liver fibrosis could alleviated by triggering the activation of apoptosis [4], senescence [5], necroptosis [6], lipocyte phenotype [7], and prevention of the proliferation [8], contractile [9], glycolytic [10] and pericyte [11] in HSCs.”
BackgroundSelf-citationLu, C., Xu, W., Zhang, F., Shao, J., & Zheng, S. (2016) · Toxicology · doi:10.1016/j.tox.2016.07.018 · Cited by 28 · cited 1×
“We previously reported that the pathological and pathophysiological condition of liver fibrosis could alleviated by triggering the activation of apoptosis [4], senescence [5], necroptosis [6], lipocyte phenotype [7], and prevention of the proliferation [8], contractile [9], glycolytic [10] and pericyte [11] in HSCs.”
BackgroundSelf-citationHarnessing liver progenitors in the treatment of liver fibrosis: a step in the right direction?
Breitkopf‐Heinlein, K., & Syn, W. (2020) · Gut · doi:10.1136/gutjnl-2019-320203 · Cited by 11
Construction of Stable Mammalian Cell Lines for Inducible Expression of G Protein-Coupled Receptors
Opefi, C. A., Tranter, D., Smith, S. O., & Reeves, P. J. (2015) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2014.12.020 · Cited by 10 · cited 1×
“According to a reported protocol, stable cell lines were constructed [25].”
BackgroundNagai, H., Kanekawa, T., Kobayashi, K., Mukozu, T., Matsui, D., Matsui, T., Kanayama, M., Wakui, N., Momiyama, K., Shinohara, M., et al. (2013) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-013-2344-1 · Cited by 9 · cited 1×
“The initial dose of sorafenib was 400 mg, taken orally twice daily after dinner and breakfast [21].”
Background
Cited by
ROS/RNS as molecular signatures of chronic liver diseases
Che, Z., Zhou, Z., Li, S.-Q., Gao, L., Xiao, J., & Wong, N.-K. (2023) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2023.08.001 · Cited by 110
Metadata
- Authors
- Shen, M., Li, Y., Wang, Y., Shao, J., Zhang, F., Yin, G., Chen, A., Zhang, Z., & Zheng, S.
- Venue
- Redox Biology
- Publisher
- Elsevier BV
- Published
- 2021-11
- Volume
- 47
- Pages
- 102151
- ISSN
- 2213-2317 (ISSN-L)
- OpenAlex
- W3203260835
- Cited by
- 231
- References
- 49
- FWCI
- 11.27
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.